PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression

10.3390/cancers14071652

Saved in:
Bibliographic Details
Main Authors: Deng, Shuo, Leong, Hin Chong, Datta, Arpita, Gopal, Vennila, Kumar, Alan Prem, Yap, Celestial T
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Review
Language:English
Published: MDPI 2023
Subjects:
AKT
Online Access:https://scholarbank.nus.edu.sg/handle/10635/237212
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-237212
record_format dspace
spelling sg-nus-scholar.10635-2372122024-04-04T04:22:42Z PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression Deng, Shuo Leong, Hin Chong Datta, Arpita Gopal, Vennila Kumar, Alan Prem Yap, Celestial T CANCER SCIENCE INSTITUTE OF SINGAPORE PHARMACOLOGY PHYSIOLOGY Science & Technology Life Sciences & Biomedicine Oncology PI3K AKT cytoskeleton cancer chemotherapy clinical trial PHASE-II TRIAL IXABEPILONE PLUS CAPECITABINE AKT INHIBITOR IPATASERTIB RESISTANT PROSTATE-CANCER ALBUMIN-BOUND PACLITAXEL ANTIBODY-DRUG CONJUGATE BREAST-CANCER INTERMEDIATE-FILAMENTS CELL-MIGRATION PHOSPHOINOSITIDE 3-KINASES 10.3390/cancers14071652 CANCERS 14 7 2023-02-14T02:12:34Z 2023-02-14T02:12:34Z 2022-03-24 2023-02-13T06:30:52Z Review Deng, Shuo, Leong, Hin Chong, Datta, Arpita, Gopal, Vennila, Kumar, Alan Prem, Yap, Celestial T (2022-03-24). PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression. CANCERS 14 (7). ScholarBank@NUS Repository. https://doi.org/10.3390/cancers14071652 2072-6694 https://scholarbank.nus.edu.sg/handle/10635/237212 en MDPI Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Oncology
PI3K
AKT
cytoskeleton
cancer
chemotherapy
clinical trial
PHASE-II TRIAL
IXABEPILONE PLUS CAPECITABINE
AKT INHIBITOR IPATASERTIB
RESISTANT PROSTATE-CANCER
ALBUMIN-BOUND PACLITAXEL
ANTIBODY-DRUG CONJUGATE
BREAST-CANCER
INTERMEDIATE-FILAMENTS
CELL-MIGRATION
PHOSPHOINOSITIDE 3-KINASES
spellingShingle Science & Technology
Life Sciences & Biomedicine
Oncology
PI3K
AKT
cytoskeleton
cancer
chemotherapy
clinical trial
PHASE-II TRIAL
IXABEPILONE PLUS CAPECITABINE
AKT INHIBITOR IPATASERTIB
RESISTANT PROSTATE-CANCER
ALBUMIN-BOUND PACLITAXEL
ANTIBODY-DRUG CONJUGATE
BREAST-CANCER
INTERMEDIATE-FILAMENTS
CELL-MIGRATION
PHOSPHOINOSITIDE 3-KINASES
Deng, Shuo
Leong, Hin Chong
Datta, Arpita
Gopal, Vennila
Kumar, Alan Prem
Yap, Celestial T
PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
description 10.3390/cancers14071652
author2 CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet CANCER SCIENCE INSTITUTE OF SINGAPORE
Deng, Shuo
Leong, Hin Chong
Datta, Arpita
Gopal, Vennila
Kumar, Alan Prem
Yap, Celestial T
format Review
author Deng, Shuo
Leong, Hin Chong
Datta, Arpita
Gopal, Vennila
Kumar, Alan Prem
Yap, Celestial T
author_sort Deng, Shuo
title PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
title_short PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
title_full PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
title_fullStr PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
title_full_unstemmed PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
title_sort pi3k/akt signaling tips the balance of cytoskeletal forces for cancer progression
publisher MDPI
publishDate 2023
url https://scholarbank.nus.edu.sg/handle/10635/237212
_version_ 1800915777348435968